Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35,428Revenue $M2,105Net Margin (%)20.2Z-Score21.8
Enterprise Value $M35,127EPS $3.8Operating Margin %36.1F-Score4
P/E(ttm))96.7Cash Flow Per Share $-2.0Pre-tax Margin (%)33.9Higher ROA y-yN
Price/Book15.010-y EBITDA Growth Rate %0Quick Ratio5.1Cash flow > EarningsY
Price/Sales15.85-y EBITDA Growth Rate %0Current Ratio5.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %35.2ROA % (ttm)14.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)21.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M101ROI % (ttm)53.3Gross Margin Increase y-yN

Gurus Latest Trades with REGN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNVanguard Health Care Fund 2014-06-30 Add0.79%$277.29 - $313.74
($296.6)
$ 354.0519%Add 60.34%2,795,500
REGNFrank Sands 2014-06-30 Add0.64%$277.29 - $313.74
($296.6)
$ 354.0519%Add 22.32%4,907,362
REGNRay Dalio 2014-06-30 Buy 0.04%$277.29 - $313.74
($296.6)
$ 354.0519%New holding, 18400 sh.18,400
REGNJoel Greenblatt 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 354.0519%New holding, 881 sh.881
REGNMario Gabelli 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 354.0519%New holding, 2295 sh.2,295
REGNVanguard Health Care Fund 2014-03-31 Add0.29%$267.62 - $347.62
($306.26)
$ 354.0516%Add 23.47%1,743,468
REGNFrank Sands 2014-03-31 Add0.22%$267.62 - $347.62
($307.2)
$ 354.0515%Add 7.48%4,012,062
REGNRon Baron 2014-03-31 Buy 0.01%$267.62 - $347.62
($307.2)
$ 354.0515%New holding, 6084 sh.6,084
REGNJoel Greenblatt 2013-12-31 Sold Out -0.03%$261.88 - $313.67
($287.35)
$ 354.0523%Sold Out0
REGNFrank Sands 2013-09-30 Add0.56%$227.65 - $309.174
($262.76)
$ 354.0535%Add 20.34%3,777,357
REGNJoel Greenblatt 2013-09-30 Buy 0.03%$227.65 - $309.174
($262.76)
$ 354.0535%New holding, 3285 sh.3,285
REGNRay Dalio 2013-09-30 Sold Out -0.01%$227.65 - $309.174
($262.76)
$ 354.0535%Sold Out0
REGNFrank Sands 2013-06-30 Add1.07%$178.51 - $282.8
($232.86)
$ 354.0552%Add 81.03%3,138,793
REGNRay Dalio 2013-06-30 Buy 0.01%$178.51 - $282.8
($232.86)
$ 354.0552%New holding, 4100 sh.4,100
REGNVanguard Health Care Fund 2013-03-31 Add0.62%$158.42 - $183.77
($171.66)
$ 354.05106%Add 170.41%1,412,100
REGNFrank Sands 2013-03-31 Reduce-1.02%$158.42 - $183.77
($171.66)
$ 354.05106%Reduce -46.22%1,733,896
REGNFrank Sands 2012-09-30 Reduce-1.2%$112.77 - $152.66
($135.2)
$ 354.05162%Reduce -37.57%3,834,373
REGNVanguard Health Care Fund 2012-09-30 Reduce-0.09%$112.77 - $152.66
($135.2)
$ 354.05162%Reduce -24.56%522,200
REGNFrank Sands 2012-06-30 Add0.2%$108.78 - $143.87
($125.43)
$ 354.05182%Add 6.5%6,142,048
REGNDodge & Cox 2012-03-31 Sold Out $57.83 - $119.96
($92.23)
$ 354.05284%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
REGN Mario Gabelli 2014-06-302,29500New Buy
REGN Ray Dalio 2014-06-3018,4000.020.04New Buy
REGN Joel Greenblatt 2014-06-3088100New Buy
REGN Vanguard Health Care Fund 2014-06-302,795,5002.772.1+60.34%
REGN Frank Sands 2014-06-304,907,3624.863.5+22.32%
REGN Ron Baron 2014-06-307,1090.010.01+16.85%
Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Aberman Michael SVP Strategy and Investor Relat 2014-08-19Sell3,611$3501.19view
McCorkle Douglas SVP Controller and Asst Treasur 2014-08-18Sell5,875$3530.33view
BROWN MICHAEL SDirector 2014-08-15Sell3,000$349.21.42view
GOLDSTEIN JOSEPH LDirector 2014-08-14Sell2,000$347.651.87view
VAGELOS P ROYChairman of the Board 2014-08-13Sell8,028$340.014.16view
VAGELOS P ROYChairman of the Board 2014-08-11Sell11,972$340.114.13view
STAHL NEILSVP Research and Development S 2014-08-11Sell11,646$339.964.18view
STAHL NEILSVP Research and Development S 2014-08-08Sell2,841$340.63.98view
Van Plew Daniel PSVP & General Mgr Industrial O 2014-08-07Sell6,806$338.374.67view
GOLDSTEIN JOSEPH LDirector 2014-08-06Sell2,000$331.26.93view

Press Releases about REGN :

    Quarterly/Annual Reports about REGN:

    News about REGN:

    Articles On GuruFocus.com
    How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
    Weekly Insider Sells Highlight: MSFT, REGN, ATVI, MAA Feb 17 2014 
    Insiders Are Buying Ophthotech Oct 08 2013 
    Weekly Top Insider Sells: REGN May 27 2013 
    comment on REGN Mar 06 2013 
    Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
    52-Week High Companies: ZMH, CVX, V, REGN, DFS Sep 10 2012 
    Regeneron Pharmaceuticals: Continuous loss making company delivers 2-year 600% gain in share price Sep 08 2012 
    52-Week High Companies: BAM, REGN, TRV, WFC Aug 20 2012 
    52-Week High Companies: EC, MAT, ORLY, V, REGN Apr 16 2012 


    More From Other Websites
    US STOCKS-S&P 500 tops 2,000; analysts see more gains ahead Aug 25 2014
    Today's Momo Momentum Stock Is Regeneron Pharmaceuticals (REGN) Aug 25 2014
    [video] Gilead 'the drug story': Cramer Aug 25 2014
    Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at... Aug 25 2014
    Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at... Aug 25 2014
    Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at... Aug 25 2014
    Qihoo Among 5 Stocks With Top Fundamentals Aug 21 2014
    Regeneron Announces Upcoming 2014 Investor Conference Presentations Aug 19 2014
    Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) to Ring The NASDAQ Stock Market Opening Bell Aug 19 2014
    Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) to Ring The NASDAQ Stock Market Opening Bell Aug 19 2014
    Regeneron Announces Upcoming 2014 Investor Conference Presentations Aug 19 2014
    [video] Hot biotech drugs Aug 19 2014
    Jazz, Celgene Lead Top 4 Drugmaker Profit Margins Aug 18 2014
    [video] Cramer: Market about Russia-Ukraine Aug 18 2014
    Regeneron CEO: How I became a billionaire Aug 17 2014
    [video] Eyeball injections equal eye-popping profits Aug 14 2014
    [video] Red hot biotech stocks Aug 14 2014
    Cramer: Is Street preparing for the worst? Aug 13 2014
    Regeneron's Eye Drug Eylea Cleared in the EU for DME Aug 12 2014
    REGENERON PHARMACEUTICALS INC Financials Aug 12 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK